Anavex Life Sciences Corp (AVXL)

[tradeherpete]

And people got better safely so, they want to stay on blarcamesine.

It's accepted that Rett is a difficult condition to assess in a clinical trial.

As in the trial, the OLE population enjoyed improvements in their condition without suffering adverse events, understandably to most, they would like to continue to enjoy those benefits they see as improving their lives.

ANAVEX®2-73 (blarcamesine) Receives Compassionate Use Authorization for Pediatric Patients with Rett Syndrome

Health Canada Special Access Program (SAP) Authorizes ANAVEX®2-73 (blarcamesine) for patients after successful completion of Open-Label Extension (OLE) study

Granting of requests are also ongoing in United Kingdom and Australia – representing all regions of Rett Syndrome study participation

https://finance.yahoo.com/news/anavex-2-73-blarcamesine-receives-113000106.html